References
- Messina M, Barnes S : The role of soy products in reducing risks of certain cancers. J Natl Cancer Inst 83:541-546, 1991
- Messina M, Persky V, Setchell KDR, Barnes S : Soy intake and cancer risk:a review of the in vitro and in vivo data. Nutr Cancer 21:113-131, 1994
- Steele VE, Pereira MA, Sigman CC, Kelloff GJ : Cancer chemoprevetntion agent development strategies for genistein. J Nutr 125:713S-716S, 1995
- Sharma OP, Adlercreutz H, Strandberg JD, Zirkin BR, Coffey DS : Soy of dietary source plays a preventive role against the pathogenesis of prostatitis in rats. J Steroid Biochem Mol Biol 43:557-564, 1992
- Mokhtar NM, El-Asser AA, El-Bolkainy MN, Ibrahim HA, El-din NB, Moharram NZ : Effect of soybean feeding on experimental carcinogenesis- III. Carcinogenicity of nitrite and dibutylamine in mice: a histopathological study. Eur J Cancer Clin Oncol 24:403-411, 1988
- Helms JR, Gallaher JJ : The effect of dietary soy protein isolate and genistein on the development of preneoplastic lesions (aberrant crypts) in rats. J Nutr 125:802S(abs.), 1995
- Makela S, Pylkkanen L, Santti R, Adlercreutz H : Effects of foods on the immune and hormonal systems, University of Zurich and Swiss Federal Institute of Technology, Switzerland, P.135-139, 1991
- Troll W, Wiesner R, Belman S, Shellabarger CJ : Inhibition of carcinogenesis by feeding diets containing soybeans. Proc Am Assoc Cancer Res 20:265(abs), 1979
- Kim JP, Park JG, Lee MD, Han MD, Park ST, Lee BH, Jung SE : Cocarcinogenic effects of several Korean foods on gastric cancer induced by N-methyl-N’-nitro-N-nitrosoguanidine in rats. Jap J Surg 15:427-437, 1985
- Shao ZM, Wu J, Shen ZZ, Barsky SH : Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res 58:4851-4857, 1998
- Kuo SM. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett 110:41-48, 1996
- Folkman J, Cotran RS : Relationship of vascular proliferation to tumor growth. Int Rev Exp Pathol 16 : 207-248, 1976
- Dickinson AJ, Fox SB, Persad J : Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. Br J Urol 74 : 762-766, 1994
- Jaeger TM, Weidner N, Chew K : Tumor angiogenesis correlates with lymph node metastasis in invasive bladder cancer. J Urol 154 : 69-71, 1995
- Takahashi Y, Kitadai Y, Bucana CD : Expression of vascular endothelial cell growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55 : 3964-3968, 1995
- Tanigawa N, Amaya H, Matsumura M : Extent of tumor vascularization correlates with the prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res 56 : 2671-2676, 1996
- Gasparini G, Harris AL: Clinical importance of the determination of tumor angiogenesis in breast carcinoma: Much more than a new prognostic tool. J Clin Oncol 13:765-782, 1995
- Leedy DA, Trune DR, Kronz JD, Weidner N, Cohen JI: Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous cell carcinoma of the tongue. Otolaryngol Head Neck Surg 111:417-422, 1994
- Williams JK, Carlson GW, Cohen C, Derose PB, Hunter S, Jurkiewicz MJ: Tumor angiogenesis as a prognostic factor in oral cavity tumor. Am J Surg 168:373-380, 1994
- Pazouki S, Chisholm DM, Adi MM, Carmichael G, Farquharson M, Ogden GR, Schor SL, Schor AM: The association between tumour progression and vascularity in the oral mucosa. J Pathol 183:39-43, 1997
- Shpitzer T, Chaimoff M, Gal R, Stern Y, Feinmesser R, Segal K: Tumor angiogenesis as a prognostic factor in early oral tongue cancer. Arch Otolaryngol Head Neck Surg 122:865-868, 1996
- Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N : Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362 : 841-844, 1993
- Barinaga M : Designing therapies that target tumor blood vessels. Science 24(275) : 482-484, 1997
- Coleman KR, Braden GA, Willingham MC, Sane DC : Vitaxin, a humanized monoclonal antibody to the vitronectin receptor (alphavbeta3), reduces neointimal hyperplasia and total vessel area after balloon injury in hypercholesterolemic rabbits. Circ Res 84 : 1268-1276, 1999 https://doi.org/10.1161/01.RES.84.11.1268
- Matsumoto K, Ninomiya Y, Inoue M, Tomioka T : Intra-tumor injection of an angiogenesis inhibitor, TNP-470, in rabbits bearing VX2 carcinoma of the tongue. Int J Oral Maxillofac Surg 28 : 118-124, 1999
- Schiller JH, Bittner G : Potentiation of platinum antitumor effects in human lung tumor xenografts by the angiogenesis inhibitor squalamine : effects on tumor neovascularization. Clin Cancer Res 5 : 4287-4294, 1999
- Moriyama M, Kumagai S, Kawashiri S, Kojima K, Kakihara K, Yamamoto E : Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma. Oral Oncol 33 : 369-374, 1997
- Denhart BC, Guidi AJ, Tognazzi K, Dvorak HF, Brown LF : Vascular permeability factor/vascular endothelial growth factor and its receptors in oral and laryngeal squamous cell carcinoma and dysplasia. Lab Invest 77 : 659-664, 1997
- Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM : Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55 : 3964-3968, 1995
- Obermair A, Kohlberger P, Bancher-Todesca D, Tempfer C, Sliutz G, Leodolter S, Reinthaller A, Kainz C, Breitenecker G, Gitsch G : Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer. Gynecol Oncol 63 : 204-209, 1996
- Wei H, Wei L, Frenkel K, Bowens R, Barnes S : Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr Cancer 20:1-12, 1993
- Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe SI, Itoh N, Shibuya M, Fukami Y : Genistein, a specific inhibitor of tyrosinespecific protein kinases. J Biol Chem 262:5592-5595, 1987
- Alberts B, Bray D, Lewis J, Raff M, et al : Molecular biology of the cell, 3rd ed. Garlane Publishing, Inc, 1994, P.759-770
- Peterson TG, Barnes S : Genistein inhibition of the growth of human breast cancer cells:independence from estrogen receptors and the multi-drug resistance gene. Biochem Biophys Res Commun 179:661-667, 1991
- Akimura K, Utsumi T, Sato EF, Klostergaard J, Inoue M, Utsumi K : Role of tyrosyl phosphorylation in neutrophil priming by tumor necrosis factor-alpha and granulocyte colony stimulating factor. Arch Biochem Biophys 298:703-709, 1992
- Fotsis T, Pepper M, Adlercreutz H, Hase T, Montesano R, Schweigerer L : Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr 125(3 Suppl):790S, 1995
- Folkman J, Shing Y : Angiogenesis. J Biol Chem 267 : 10931-10934, 1992
- Folkman J : What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82 : 4-6, 1990
- Tokumo K, Kodama J, Seki N, Nakanishi Y, Miyagi Y, Kamimura S, Yoshinouchi M, Okuda H, Kudo T : Different angiogenic pathways in human cervical cancers. Gynecol Oncol 68 : 38-44, 1998
- Winlaw DS : Angiogenesis in the pathobiology and treatment of vascular and malignant diseases. Ann Thorac Surg 64 : 1204-1211, 1997 https://doi.org/10.1016/S0003-4975(97)00716-9
- Takahashi Y, Kitadai Y, Bucana CD : Expression of vascular endothelial cell growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55 : 3964-3968, 1995
- Verheul HM, Panigrahy D, Yuan J, D’Amato RJ : Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbits. Br J Cancer 79 : 114-118, 1999 https://doi.org/10.1038/sj.bjc.6690020
- Kotoh T, Dhar DK, Masunaga R, Tabara H, Tachibana M, Kubota H, Kohno H, Nagasue N : Antiangiogenic therapy of human esophageal cancers with thalidomide in nude mice. Surgery 125 : 536-544, 1999
- Myoung H, Hong SD, Kim YY, Hong SP, Kim MJ: Evaluation of the anti-tumor and anti-angiogenic effect of paclitaxel and thalidomide on the xenotransplanted oral squamous cell carcinoma. Cancer Letters 163:191-200, 2001